Key result
Anticoagulant therapy with heparin and warfarin successfully resolved a massive left ventricular thrombus and improved symptoms in a patient with dilated cardiomyopathy.
Why the study?
The connection between cardiac thrombus formation and conditions such as gout and methamphetamine abuse is not thoroughly studied.
Does anticoagulant therapy resolve left ventricular thrombus and improve symptoms in a patient with dilated cardiomyopathy and multiple cardioembolic attacks?
Case Report (n=1)
No
Does anticoagulant therapy resolve left ventricular thrombus and improve symptoms in a patient with dilated cardiomyopathy and multiple cardioembolic attacks?
Anticoagulant therapy successfully resolved a large left ventricular thrombus and improved symptoms in a patient with dilated cardiomyopathy and multiple cardioembolic attacks.
Answers are grounded in this paper and cite their sources.
May support anticoagulation for LV thrombus in dilated cardiomyopathy; leaves open need for prospective confirmation.
Left ventricular thrombus is one of the major complications of dilated cardiomyopathy. Although the presence of a cardiac thrombus is a major risk factor for embolization, several probable conditions, the connection of which is not thoroughly studied, such as gout disease and methamphetamine abuse, are also possible causes. We present the case report of a male in his early 40s with a history of alcohol and methamphetamine abuse, gout, and dilated cardiomyopathy, experiencing multiple ischemic attacks, including acute limb ischemia, dysarthria, and renal infarct. Echocardiography revealed a large clot in the left ventricle. The patient received heparin at a rate of 1000 units/hour, followed by warfarin at 10 mg/day, and probenecid at 500 mg/day. The thrombus resolved upon anticoagulant therapy, with improvement in the patient's symptoms. Left ventricular thrombus formation in dilated cardiomyopathy is influenced by many factors, including drug toxicity (for instance, methamphetamine), uric acid levels, and N-terminal precursor B-type natriuretic peptide. The thrombus can cause cardioembolic attacks in multiple sites, and the choice for emergent therapy is an oral anticoagulant, which may improve the ejection fraction. However, certain aspects related to cardiac thrombosis and embolization risk still warrant more comprehensive studies.
No takes yet. Share an insight, caveat, or question.
Moayerifar et al. (2025) conducted a case report in Dilated cardiomyopathy with left ventricular thrombus (n=1). Anticoagulant therapy (heparin and warfarin) was evaluated on Thrombus resolution and symptom improvement. Anticoagulant therapy with heparin and warfarin successfully resolved a massive left ventricular thrombus and improved symptoms in a patient with dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: